Overview

A Study for Adult Patients With Fibromyalgia

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine if 30 milligrams (mg) of duloxetine is effective in the treatment of fibromyalgia compared to placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride